Literature DB >> 15307137

Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc.

Christine Lyn Le Maitre1, Anthony J Freemont, Judith Alison Hoyland.   

Abstract

The histological and biochemical changes that occur in the extracellular matrix of the intervertebral disc (IVD) during ageing and degeneration have been investigated extensively. However, the mechanisms behind these changes are not fully understood. A number of studies have suggested the involvement of matrix metalloproteinases (MMPs) and ADAMTS in IVD degeneration, but few have localized the site of production of these enzymes to the cells of the degenerate disc. This study uses immunohistochemical techniques to localize and quantify the production of degrading enzymes (MMPs 1, 3, and 13, and ADAMTS 4) and their inhibitors (TIMPS 1, 2, and 3) within non-degenerate and degenerate discs of varying severity of degeneration. In all discs investigated, the cells that produced the enzymes and their inhibitors were the chondrocyte-like cells of the nucleus pulposus and inner annulus fibrosus (AF), with little immunopositivity in the outer AF. Non-degenerate discs showed low numbers of cells expressing the degradative enzymes MMP 1 and ADAMTS 4, suggesting a role for these enzymes in normal homeostasis. No MMP 3 or MMP 13 immunopositivity was observed in non-degenerate discs. In degenerate discs, the number of cells immunopositive for MMPs 1, 3, 13 and ADAMTS 4 increased with the severity of degeneration. This increase in degrading enzymes was also accompanied by increases in the number of cells immunopositive for TIMPs 1 and 2 but not TIMP 3. This study highlights that although the expression of a number of MMPs increases with degeneration, this is accompanied by an increase in their inhibitors. However, the increase in the number of cells immunoreactive for ADAMTS 4 with increasing degeneration was not paralleled by a rise in its inhibitor TIMP 3. This finding indicates that the aggrecanases, rather then the MMPs, are a possible therapeutic target for the inhibition of disc degeneration. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307137     DOI: 10.1002/path.1608

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  163 in total

1.  The pathophysiologic role of the protein kinase Cδ pathway in the intervertebral discs of rabbits and mice: in vitro, ex vivo, and in vivo studies.

Authors:  Michael B Ellman; Jae-Sung Kim; Howard S An; Jeffrey S Kroin; Xin Li; Di Chen; Dongyao Yan; Doug D Buechter; Keiichi Nakayama; Bo Liu; Stephanie Morgan; Hee-Jeong Im
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  Enhancement of intervertebral disc cell senescence by WNT/β-catenin signaling-induced matrix metalloproteinase expression.

Authors:  Akihiko Hiyama; Daisuke Sakai; Makarand V Risbud; Masahiro Tanaka; Fumiyuki Arai; Koichiro Abe; Joji Mochida
Journal:  Arthritis Rheum       Date:  2010-10

3.  Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation.

Authors:  Alexandros Tsarouhas; Giannoula Soufla; Pavlos Katonis; Dritan Pasku; Antonis Vakis; Demetrios A Spandidos
Journal:  Eur Spine J       Date:  2010-09-22       Impact factor: 3.134

4.  A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.

Authors:  Christine L Le Maitre; Anthony J Freemont; Judith A Hoyland
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

5.  An in vitro tissue model to study the effect of age on nucleus pulposus cells.

Authors:  R A Kandel; D Hamilton; C Séguin; S-Q Li; C Arana; R Pilliar
Journal:  Eur Spine J       Date:  2007-08-18       Impact factor: 3.134

Review 6.  An understanding of intervertebral disc development, maturation and cell phenotype provides clues to direct cell-based tissue regeneration therapies for disc degeneration.

Authors:  Ricardo Rodrigues-Pinto; Stephen M Richardson; Judith A Hoyland
Journal:  Eur Spine J       Date:  2014-04-29       Impact factor: 3.134

7.  Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Hua Wang; Ye Tian; Jianru Wang; Kate L E Phillips; Abbie L A Binch; Sara Dunn; Alison Cross; Neil Chiverton; Zhaomin Zheng; Irving M Shapiro; Christine L Le Maitre; Makarand V Risbud
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

Review 8.  Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis.

Authors:  Michael B Ellman; Howard S An; Prasuna Muddasani; Hee-Jeong Im
Journal:  Gene       Date:  2008-05-09       Impact factor: 3.688

9.  Inflammatory cytokine and catabolic enzyme expression in a goat model of intervertebral disc degeneration.

Authors:  Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Yian Khai Lau; Zhirui Jiang; George R Dodge; Dawn M Elliott; Robert L Mauck; Neil R Malhotra; Lachlan J Smith
Journal:  J Orthop Res       Date:  2020-03-03       Impact factor: 3.494

10.  Cyclic tensile stress exerts a protective effect on intervertebral disc cells.

Authors:  Gwendolyn Sowa; Sudha Agarwal
Journal:  Am J Phys Med Rehabil       Date:  2008-07       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.